BAF Holding coordinates compliant international wholesale supply of premium indoor medical cannabis flower sourced from licensed EU-GACP cultivation partners in Thailand and processed through EU-GMP manufacturing partners in Portugal and the Czech Republic for regulated markets including Germany and Australia.
BAF Holding Pty Ltd is a Thailand-based medical cannabis supply and commercial coordination company focused exclusively on supplying regulated international medical markets, including Australia and Europe.
We work with licensed EU-GACP cultivation partners in Thailand and licensed EU-GMP manufacturing partners to provide compliant supply pathways for regulated medical cannabis supply chains. Product specifications, quality requirements and supply programs are developed in collaboration with licensed importing partners and applicable regulatory requirements.
Our operations are structured specifically for licenced importers, manufacturers, and medical distributors.
Operating in regulated medical cannabis markets requires discipline, documentation and traceability. Our compliance framework is designed to support the regulatory and quality requirements of licensed importers, manufacturers and regulators throughout the international medical cannabis supply chain.
Our supply chain management and documentation systems are designed to support efficient downstream EU-GMP processing, batch release and import certification.
Why Choose BAF Holding
For more information, contact our Licensed Supply Team.
We work with licensed international importers, manufacturers and distribution partners, supporting compliant medical cannabis supply into regulated international markets.
Our supply programs are aligned with:
We offer flexible supply formats:
BAF Holding supports customer-specific supply programs tailored to licensed importer and manufacturer requirements. Programs may include preferred genetics, cannabinoid and terpene profiles, packaging configurations, and production planning aligned with commercial and regulatory requirements.
Where commercially appropriate, selected proprietary strain names may also be supplied under agreed commercial arrangements.
BAF Holding sources premium indoor medical cannabis flower from licensed cultivation partners, with product specifications developed in collaboration with licensed importing partners and applicable regulatory requirements.
Products are sourced from licensed cultivation partners operating under documented cultivation, quality and post-harvest procedures aligned with internationally recognised standards.
Product specifications including; THC range, moisture content, irradiation requirements, packaging format, and stability data are defined in collaboration with the licensed importing partner and applicable regulatory authorities.
For more information, contact our Licensed Supply Team.
Thailand provides a regulated cultivation environment, with products sourced from licensed cultivation partners operating within BAF Holding’s international medical cannabis supply model.
Medical cannabis cultivated in Thailand is not supplied directly to patients or retail markets. Instead, material is structured exclusively for:
We prioritise:
Our objective is to be a trusted, audit-ready international medical cannabis supply partner, coordinating compliant international supply through licensed cultivation, manufacturing, import and distribution partners for regulated markets in Australia and Europe.
Compliance is central to every transaction undertaken by BAF Holding. BAF Holding coordinates compliant international medical cannabis supply through licensed cultivation, manufacturing, import and distribution partners. Every supply chain is managed in accordance with the regulatory requirements of both the exporting and importing jurisdictions.
For more information, contact our Licensed Supply Team.
All engagements are subject to formal contractual agreements and regulatory approval.
Our operations are structured to support licensed importers, manufacturers and medical distributors operating in regulated medicinal cannabis markets.
A cannabis variety defined by its chemical profile, rather than name alone.
Laboratory document confirming product quality and specifications.
The European Union’s GMP framework governing pharmaceutical manufacturing.
Thailand's authority to protect consumers' health by ensuring safety, quality and efficacy of consumable products.
International guidelines for the cultivation, collection and post-harvest handling of medicinal plants to support quality and traceability.
Pharmaceutical manufacturing standards required for medicinal products.
Australia’s Office of Drug Control oversees the licensing and regulation of medicinal cannabis cultivation, manufacture and import under the Australian Government.
An appropriately qualified individual responsible for ensuring that each batch of medicinal product complies with applicable regulatory and GMP standards prior to batch release.
Australia’s pharmaceutical regulator.
For more information, contact our Licensed Supply Team.
Find clear answers to common inquiries about our medical cannabis operations, compliance, and licensing.
Regulated Medicinal Cannabis Supply Enquiry
BAF Holding Pty Ltd coordinates compliant international medicinal cannabis supply through licensed cultivation, manufacturing, import and distribution partners serving regulated markets in Australia and Europe.
Our operations are designed to support compliant international sourcing, with a clear pathway aligned to Australian and EU regulatory frameworks.
We welcome enquiries related to:
This form is intended for licensed medicinal cannabis businesses only.
* indicates required information